Seaport Therapeutics Inc. Common Stock
SPTX | NASDAQ
$19.60
-$1.50 (-7.11%)
At close: Oct 30, 2026, 4:00 PM ET
$19.21
-$0.39 (-1.99%)
Pre-market:
Nov 2, 2026, 7:53 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 |
|---|---|
Revenue | n/a |
Cost of Revenue | n/a |
Gross Profit | n/a |
Operating Income | -87.29M |
Interest Income | 11.4M |
Pretax Income | -74.11M |
Net Income | -74.88M |
Selling & General & Admin | 20.98M |
Research & Development | 66.31M |
Other Expenses | n/a |
Operating Expenses | 87.29M |
Interest Expense | n/a |
Selling & Marketing Expenses | n/a |
Cost & Expenses | 87.29M |
Income Tax Expense | 773K |
Shares Outstanding (Basic) | 38.65M |
Shares Outstanding (Diluted) | 38.65M |
EPS (Basic) | -1.94 |
EPS (Diluted) | -1.94 |
EBITDA | -85.89M |
EBIT | -87.29M |
Depreciation & Amortization | 1.41M |
Add to Watchlist
Select watchlists to add or remove SPTX